P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne

Completed · Phase 3 · Has a placebo group

Conditions studied: Acne Vulgaris

In brief

This is a 12 week, multi-center, double-blinded, randomized, vehicle-controlled, parallel group, study to be conducted in approximately 1300 subjects with acne vulgaris in the US.

Key facts

Study ID
NCT02667444
Run by
Novan, Inc.
People needed
1330
Starts
2016-02-19
Expected to finish
2016-12-09
Last updated by the study team
2023-07-24

Who can join

Age: 9 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.